Your trusted destination for CME, CPD & Medical Education across the Middle East.
National Oncology Center, Royal Hospital, Oman
Dr. Thuraiya Al Hajri is a senior consultant radiation oncologist based in Muscat, Oman. She serves as Head of Radiation Oncology at the National Oncology Center, Royal Hospital, where she leads the delivery of specialist radiation treatment for patients with cancer. She has more than 15 years of experience in radiation oncology, with expertise in advanced radiation techniques and multidisciplinary cancer management.
Dr. Al Hajri completed her medical education at Sultan Qaboos University in Oman and subsequently pursued specialist training in radiation oncology through international residency and fellowship programmes. Her postgraduate professional training includes experience in Germany, Canada, Scotland, and England. She holds the qualification of FRCPC (Fellow of the Royal College of Physicians and Surgeons of Canada), reflecting advanced specialist training in her field.
Her clinical expertise includes modern radiation treatment techniques such as stereotactic body radiotherapy (SBRT), intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and three-dimensional conformal radiotherapy (3D-CRT). These technologies allow radiation oncologists to deliver carefully planned treatment to cancerous areas while limiting radiation exposure to surrounding healthy tissues.
As Head of Radiation Oncology, Dr. Al Hajri contributes to the development and implementation of advanced radiotherapy services. Her leadership includes supporting multidisciplinary cancer treatment, coordinating specialist teams, and improving access to precision radiation treatment. She has also contributed to the implementation of SBRT programmes and the development of regional oncology services.
Her research and academic interests include the management of complex cancers, radiation treatment outcomes, and the application of advanced radiotherapy techniques. She has co-authored research published in the Journal of Radiotherapy in Practice, including a 2022 case report on adjuvant radiotherapy for primary cardiac sarcoma. This publication reflects her involvement in the treatment and scientific discussion of rare malignancies.
Dr. Al Hajri is also active in professional oncology leadership. She serves as Treasurer of the Oman Society of Oncology, contributing to the organization's professional and scientific activities. Through her clinical responsibilities, academic involvement, and professional leadership, she supports the continued development of cancer treatment in Oman and the wider region.

Omani Society of Oncology
Omani Society of Oncology
